TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06019533 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06180174 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05349591 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05552287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05198336 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06109142 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06024408 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT05438589 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04381468 — Predictive Biomarker (PRD): SEMA4D mRNA
Genes: SEMA4D; C9orf164; CD100; SEMAJ
Study NCT05101902 — Predictive Biomarker (PRD): CYP21A2 mRNA
Genes: CYP21A2; CYP21; CYP21B
Study NCT06243406 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06243406 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04712877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04712877 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04712877 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04712877 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04712877 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04712877 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04712877 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04712877 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06031727 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06031727 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05156554 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05400967 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05699265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04777435 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06490744 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04967079 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06409039 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT05979376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05396079 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05396079 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06374238 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04598009 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04672564 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06215014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04274426 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT05242055 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04638231 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05375461 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05375461 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05375461 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05375461 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05375461 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05375461 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06501287 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06501287 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04983095 — Predictive Biomarker (PRD): PSMA7 mRNA
Genes: PSMA7; HSPC
Study NCT04983095 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04937465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05735327 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05630521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06444464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05604495 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06649240 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05803876 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05803876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05825833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06599216 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06599216 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06599216 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06599216 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04967235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04896047 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT06602778 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT06602778 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT06602778 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04785170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04892693 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04892693 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05265715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05265715 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05265715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05627414 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06599177 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06589947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06600880 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05349851 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05349851 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06597682 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06538740 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05788744 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06283069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04603105 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05491811 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05491811 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06621563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06621563 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06622057 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06621901 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study NCT06621901 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05337787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06344845 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06467708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05046847 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT05046847 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT05046847 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT05656768 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05132712 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04776018 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04688151 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT05189093 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05958004 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04963985 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04954742 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05491018 — Predictive Biomarker (PRD): PIM3 mRNA
Genes: PIM3
Study NCT04183738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04902703 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05427136 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05676684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05077033 — Safety Biomarker (SAF): Interleukin 12
Study NCT06097442 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06539962 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT06539962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05563012 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06490796 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05722873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06199557 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05375968 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04966117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03761511 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT06075342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05418673 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT05774925 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study NCT05774925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05799079 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT06052163 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05570058 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06042777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04520711 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05111444 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05111444 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00113776 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05991414 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05043571 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04870411 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05842616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05551715 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT05874050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05288595 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05487898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05896514 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04477590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06198803 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04482660 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05147272 — Predictive Biomarker (PRD): PKMYT1 mRNA
Genes: PKMYT1; MYT1
Study NCT04918030 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT04865276 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05642455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00001069 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06466031 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05905120 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT04956003 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06562582 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06562582 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05666336 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT04425967 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05641870 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06332079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05800210 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04852328 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06490627 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT06490627 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study NCT05970588 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04569747 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04569747 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06290349 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04932876 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06035861 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04887935 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05847192 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05996601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05760898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06293248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05759728 — Predictive Biomarker (PRD): LGR5 mRNA
Genes: LGR5; GPR49; GPR67
Study NCT05065957 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT05361655 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05361655 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05361655 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05361655 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05565716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05177653 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05123040 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04865627 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04382950 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05684406 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05846243 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06291857 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06653296 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06580535 — Predictive Biomarker (PRD): PLCE1 mRNA
Genes: PLCE1; KIAA1516; PLCE; PPLC
Study NCT06580535 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05764265 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05764265 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04770389 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05645874 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT04697264 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04697264 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05022524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05679388 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05675540 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05294289 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05390112 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05981235 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05525416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06366711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06204042 — Predictive Biomarker (PRD): ITGA2B mRNA
Genes: ITGA2B; GP2B; ITGAB
Study NCT06204042 — Predictive Biomarker (PRD): ITGB3 mRNA
Genes: ITGB3; GP3A
Study NCT06204042 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT04992689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04992689 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06652425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06653712 — Predictive Biomarker (PRD): PAICS mRNA
Genes: PAICS; ADE2; AIRC; PAIS
Study NCT04701138 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05182567 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06548230 — Predictive Biomarker (PRD): IL1RAP mRNA
Genes: IL1RAP; C3orf13; IL1R3
Study NCT05388110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06201897 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT05562479 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04560166 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05531656 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06487988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05983965 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT05729399 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05729399 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06543745 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05367778 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06652152 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT06652152 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT06396884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05598593 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05598593 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06313515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05109442 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05575037 — Predictive Biomarker (PRD): Interleukin 4 receptor alpha
Genes: IL4R; IL4RA; 582J2.1
Study NCT06313086 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05538741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05861167 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT05623930 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06066346 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06073015 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05387122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05415475 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04095546 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04095546 — Predictive Biomarker (PRD): NR3C1 mRNA
Genes: NR3C1; GRL
Study NCT04095546 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT04095546 — Predictive Biomarker (PRD): MAOA mRNA
Genes: MAOA
Study NCT04095546 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT04095546 — Safety Biomarker (SAF): BDNF
Study NCT04628338 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT05036486 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06261073 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT06261073 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06261073 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT06261073 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT06261073 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study NCT06603168 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study NCT06593717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06600958 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05797987 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06586294 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06586294 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06489496 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06158542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06186076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05374226 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT04778436 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06598995 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06588023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04945668 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT06119737 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04986306 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04986306 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06542302 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT05263869 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05461976 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04998331 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05539768 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte